Italian cohort of ipilimumab expanded access programme (EAP): Efficacy, safety, and correlation with mutation status in metastatic melanoma patients.
暂无分享,去创建一个
P. Ascierto | E. Simeone | P. Queirolo | M. Mandalà | M. Guida | V. Chiarion-Sileni | G. Rinaldi | M. Aglietta | G. Parmiani | V. Ferraresi | P. Ferrucci | M. Altomonte | F. Spagnolo | R. Ridolfi | M. Bernengo | M. Vecchio | A. Scoppola | L. Guardo | J. Pigozzo | R. Marconcini